FLT3-IN-12 is a potent, selective, and orally active FLT3 kinase inhibitor with IC50 values of 1.48 nM and 2.87 nM against FLT3-WT and FLT3-D835Y, respectively; it exhibits >1000-fold selectivity over c-KIT and demonstrates excellent anti-acute myeloid leukemia activity (IC50 = 0.75 nM in MV4-11 cells).